Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis
Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells
Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
The role of idiotype vaccines in the treatment of human B-cell malignancies
[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus
Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders
Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
MTH-68/H oncolytic viral treatment in human high-grade gliomas
Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells
Immunological treatment of ovarian cancer
The immune response to breast cancer, and the case for DC immunotherapy
DC-based immunotherapy of B-cell malignancies
Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
Dendritic cell-based therapeutics for breast cancer
Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results